MRI-guided ablation of breast cancer: where do we stand today?

PET and MRI-guided focused ultrasound surgery for hypoxic-tissue ablation combined with radiotherapy in solid tumors

Background: The rationale was to develop an ablation approach to destroy regions of tumor resistant to radiation and thus reduce the time required for whole tumor ablation, while improving overall tumor control after radiotherapy. Materials and Methods: The system is composed of a micro positron emission tomography (mPET), 7T magnetic resonance imaging (MRI), and a customized MRI-compatible foc...

The Battle Against COVID-19: Where Do We Stand Now?

A new noninvasive approach in breast cancer therapy using magnetic resonance imaging-guided focused ultrasound surgery.

An ideal vision of modern medicine includes tumor surgery with the human body remaining completely intact. A noninvasive therapy could avoid infections and scar formation; it would require less anesthesia, reduce recovery time, and possibly also reduce costs. This study investigated whether human breast cancer can be effectively treated with a novel combination of image guidance and energy deli...

Mr-guided Focused Ultrasound Surgery of Breast Cancer

Background Among presently available modalities, MRI is considered to provide the closest images of breast cancer (BC) to pathological findings. MR-Guided Focused Ultrasound Surgery (MRgFUS) is a recently developed non-invasive thermal ablation system. MRgFUS system is composed of a treatment device (Exablate2000, InSightec Inc., Israel) to focus ultrasound beams to produce sharply localized hi...

MRI-guided interventions for the treatment of prostate cancer.

OBJECTIVE The purpose of this article is to evaluate MRI-guided therapies and to investigate their feasibility for focal therapy in prostate cancer patients. Relevant articles were retrieved using the PubMed online search engine. CONCLUSION Currently, MRI-guided laser ablation and MRI-guided focused ultrasound are the most promising options for focal treatment of the prostate in patients with...